Results from the 5-year SQ grass SLIT-tablet asthma prevention (GAP) trial in children with grass pollen allergy
SQ grass SLIT-tablet treatment prevented asthma symptoms and asthma medication use in children with grass pollen ARC and no pre-existing asthma. This disease-modifying effect persisted after end of treatment.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου